Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | Porustobart |
| Synonyms | |
| Therapy Description |
Porustobart (HBM4003) is an antibody against cytotoxic T lymphocyte-associated protein 4 (CTLA-4), which may stimulate anti-tumor immune response (PMID: 40378055). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| Porustobart | HBM4003|HBM 4003|HBM-4003 | CTLA4 Antibody 34 | Porustobart (HBM4003) is an antibody against cytotoxic T lymphocyte-associated protein 4 (CTLA-4), which may stimulate anti-tumor immune response (PMID: 40378055). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|